2016
DOI: 10.1167/iovs.16-19247
|View full text |Cite
|
Sign up to set email alerts
|

Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid

Abstract: PurposeOcular mucous membrane pemphigoid (OcMMP) is a rare autoimmune disorder resulting in progressive conjunctival fibrosis and ocular surface failure leading to sight loss in up to 50%. This study was designed to optimize an ocular surface sampling technique for identification of novel biomarkers associated with disease activity and/or progressive fibrosis.MethodsFifty-seven patients with OcMMP underwent detailed examination of conjunctival inflammation and fibrosis using fornix depth measurement. Ocular su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 55 publications
0
18
0
Order By: Relevance
“…In fact, IL‐8 plays an important role in acute inflammation by recruiting inflammatory cells, including neutrophils, and inducing fibrotic processes (Williams et al. ). In addition, IL‐8 exerts angiogenic effect (Yoshida et al.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In fact, IL‐8 plays an important role in acute inflammation by recruiting inflammatory cells, including neutrophils, and inducing fibrotic processes (Williams et al. ). In addition, IL‐8 exerts angiogenic effect (Yoshida et al.…”
Section: Discussionmentioning
confidence: 99%
“…Since neutrophils’ infiltration has been observed in patients with oMMP associated with progression of conjunctival scarring, also in the absence of active inflammation (Williams et al. ), a major role of this cytokine may be hypothesized also in oMMP.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…96 However, despite the absence of clinical signs of inflammation, there may still be significant cellular infiltrate on histological evaluation ('white inflammation'). 67,97,98 Further systemic immunosuppression with potential systemic toxicity may not necessarily be helpful in these cases, for whom more specific local therapy targeting the cellular infiltrate or fibrogenic process would be ideal. There is evidence for both ongoing residual subclinical inflammation 68,69 and transformed profibrotic fibroblasts 77 as the putative drivers of scarring which progresses, despite apparent clinical control of inflammation with systemic immunosuppression.…”
Section: Use Of Systemic Immunomodulation To Control Immunemediated Imentioning
confidence: 99%
“…Some progress has been made using neutrophils and their products for this. 97,114 Expression of genes that are upand downregulated in inflammation and scarring may also be worth investigating for this purpose.…”
Section: Biomarkers Of Disease Activitymentioning
confidence: 99%